Tivozanib's FDA approval for mRCC was a long time in the making, but what is its role?
Disappointing atezolizumab results for adjuvant treatment of bladder cancer (IMvigor-010).
Preliminary data on antibody responses to COVID-19 vaccination in cancer patients.
